Flavonoids as Modulators of Amyloid Precursor Protein Metabolism and Alzheimer Disease Pathology
Alzheimer disease (AD) is a progressive neurodegenerative disorder pathologically characterized by deposition of ß-amyloid (Aß) peptides as plaques in the brain. Central to this AD pathology is mismetabolism of the amyloid precursor protein (APP). Recent studies suggest that flavonoids, a class of s...
Main Author: | Rezai-Zadeh, Kavon |
---|---|
Format: | Others |
Published: |
Scholar Commons
2008
|
Subjects: | |
Online Access: | https://scholarcommons.usf.edu/etd/473 https://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=1472&context=etd |
Similar Items
-
Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein
by: Saoussen Ben Halima, et al.
Published: (2016-03-01) -
Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients
by: Martina Zimmermann, et al.
Published: (2005-06-01) -
Antihyperlipidemic effect of diosmin: A citrus flavonoid on lipid metabolism in experimental diabetic rats
by: Subramani Srinivasan, et al.
Published: (2013-01-01) -
A Role for Presenilin 1 in Regulating the Delivery of Amyloid Precursor Protein to the Cell Surface
by: Jae Yoon Leem, et al.
Published: (2002-10-01) -
Transient pharmacologic lowering of Aβ production prior to deposition results in sustained reduction of amyloid plaque pathology
by: Das Pritam, et al.
Published: (2012-08-01)